Current research has primarily focused on animal models and cellular experiments, with no direct reports of clinical trials specifically investigating autophagy pathways such as AMPK/mTOR and TFEB in human NAFLD. The gene discussed is MTOR; the disease is metabolic dysfunction-associated steatotic liver disease.